Virological markers of progression: a UK experience
Loveday, C.
Journal of Biological Regulators and Homeostatic Agents 9(3): 100-104
1995
ISSN/ISBN: 0393-974X PMID: 8782016 Document Number: 452691
Document emailed within 1 workday
Related Documents
Gariglio, R.; Taborda, M.A.; Bortolozzi, Rúl.; McDermott, J.L.; Martini, I.; Borgognone, M.; Villanova, G.Vanina.; Varnier, O.E.; Giri, A.A. 2004: Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA Medicina 64(5): 419-428Rodriguez-Frias, F.; Jardi, R.; Schaper, M.; Buti, M.; Ferrer-Costa, C.; Tabernero, D.; Homs, M.; Esteban, R. 2008: Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response Antiviral Therapy 13(8): 991-999
Schena, F.P.; Gesualdo, L. 2001: Markers of progression in IgA nephropathy Journal of Nephrology 14(6): 554-574
Gupta, V.; Gupta, S. 2004: Laboratory markers associated with progression of HIV infection Indian Journal of Medical Microbiology 22(1): 7-15
Serov, V.V.; Iushkov, P.V.; Ivanov, P.K. 1993: Possible markers of the progression and ulcerogenesis of stomach cancer Arkhiv Patologii 55(2): 9-12
Mukai, Y.; Murata, M. 2017: Japan Parkinson's Progression Markers Initiative (J-PPMI) Nihon Rinsho. Japanese Journal of Clinical Medicine 75(1): 151-155
Conri, C.; Simonoff, M.; Constans, J.; Fleury, H. 1992: Are zinc and selenium markers of progression in HIV infected patients? Presse Medicale 21(30): 1435
Grandjouan, S.; Henry, I.; Haliassos, A. 1991: Molecular analysis of genes involved in colorectal tumors. Markers of tumor predisposition and progression Gastroenterologie Clinique et Biologique 15(1): 34-48
Schechter, M.; Harrison, L.H.; Halsey, N.A.; Trade, G.; Santino, M.; Moulton, L.H.; Quinn, T.C. 1994: Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression JAMA 271(5): 353-357
Fernandes, A.P.M.; Gonçalves, M.A.G.; Machado, A.A.; Miyeko, H.; Elucir, G.; Donadi, E.A.; Rodrigues, M.d.L.V. 2005: Greater survival among patients with immunogenetic markers of rapid progression to AIDS: subsidies for nursing care Revista Latino-Americana de Enfermagem 13(2): 229-234
Korytina, G.F.; Tselousova, O.S.; Akhmadishina, L.Z.; Victorova, E.V.; Zagidullin, S.Z.; Victorova, T.V. 2012: Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease Molekuliarnaia Biologiia 46(3): 487-499
Tennenbaum, T.; Yuspa, S.H.; Grover, A.; Castronovo, V.; Sobel, M.E.; Yamada, Y.; De Luca, L.M. 1992: Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression Cancer Research 52(10): 2966-2976
Singer, S.; Souza, K.; Thilly, W.G. 1995: Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study Cancer Research 55(22): 5140-5145
Osminin, S.V.; Vetshev, F.P.; Rudenko, V.V.; Zaletaev, D.V.; Khorobrykh, T.V.; Nemtsova, M.V. 2016: The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus Klinicheskaia Laboratornaia Diagnostika 61(10): 681-685
Sheneef, A.; Gouda, A.M.; Mohammad, A.N.; Yousef, L.M.; Noureldin, A.K. 2017: Serum MicroRNA-122 and MicroRNA-155: Markers of Disease Progression in Hepatitis C viral infection Egyptian Journal of Immunology 24(2): 33-46
Kamysheva, E.S.; Kutyrina, I.M.; Nosikov, V.V.; Shvetsov, M.Iu.; Gorashko, N.M.; Ignat'ev, I.V.; Voron'ko, O.E.; Shilo, V.Iu.; Aliaev, I.G.; Shilov, E.M. 2004: Association of the complex of polymorphic markers of ACE genes, aldosteron synthetase and endothelial synthetase of nitric oxide with progression of chronic glomerulonephritis Terapevticheskii Arkhiv 76(9): 16-20
Chattopadhya, D.; Baveja, U.K.; Bose, M.; Kumar, A. 2002: Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell values: evaluation of repeat CD4+ cell evaluation vs. other immunological parameters Journal of Tropical Pediatrics 48(6): 340-347
Bunyaratavej, N. 2009: Practical experience in some aspects of bone markers Journal of the Medical Association of Thailand 92 Suppl 5: S116-S120
Barzell, W.E.; Whitmore, W.F. 1979: Clinical significance of biologic markers: Memorial Hospital experience Seminars in Oncology 6(1): 48-52
Morelli, M.; Nardi, M.; Valle, M.; Balducci, D.; Serafini, D.; Bernardini, P. 1985: Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms Minerva Medica 76(34-35): 1529-1531